Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 24;2(2):CD016192.
doi: 10.1002/14651858.CD016192.

Effectiveness of SARS-CoV-2 testing strategies

K M Saif-Ur-Rahman  1   2 , Nadra Nurdin  3 , Ani Movsisyan  4 , Kavita Kothari  5 , Thomas Conway  1   2   6 , Marie Tierney  1   2 , Petek Eylul Taneri  1   2 , Deirdre Mulholland  7 , Andrea C Tricco  8   9 , Jacqueline Dinnes  10   11 , Declan Devane  1   2   6
Affiliations

Effectiveness of SARS-CoV-2 testing strategies

K M Saif-Ur-Rahman et al. Cochrane Database Syst Rev. .

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness of different SARS-CoV-2 testing strategies in reducing COVID-19 cases, hospitalisations, and deaths among suspected cases and asymptomatic individuals.

PubMed Disclaimer

Conflict of interest statement

KM Saif‐Ur‐Rahman: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Nadra Nurdin: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Ani Movsisyan: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Kavita Kothari: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Thomas Conway: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Marie Tierney: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Petek Eylul Taneri: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Deirdre Mulholland: declares no commercial or non‐commercial conflicts of interest relevant to this review.

Andrea C Tricco: receives a support through a Tier 1 Canada Research Chair in Knowledge Synthesis for Knowledge Users and declares no commercial or non‐commercial conflicts of interest relevant to this review.

Jacqueline Dinnes: is a Cochrane editor but was not involved in the editorial process for this review and declares no commercial or non‐commercial conflicts of interest relevant to this review.

Declan Devane: declares no commercial or non‐commercial conflicts of interest relevant to this review.

References

    1. Al-Awwal N, Dweik F, Mahdi S, El-Dweik M, Anderson SH. A review of SARS-cov-2 disease (COVID-19): pandemic in our time. Pathogens 2022;11(3):368. [DOI: 10.3390/pathogens11030368] - DOI - PMC - PubMed
    1. WHO Coronavirus (COVID‐19) Dashboard. https://data.who.int/dashboards/covid19/cases?n=c 2023.
    1. Da Silva SJ, Do Nascimento JC, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, Da Silva PG, et al. Two years into the COVID-19 pandemic: lessons learned. ACS Infectious Diseases 2022;8(9):1758-814. [DOI: 10.1021/acsinfecdis.2c00204] - DOI - PMC - PubMed
    1. Hale T, Angrist N, Hale AJ, Kira B, Majumdar S, Petherick A, et al. Government responses and COVID-19 deaths: Global evidence across multiple pandemic waves. PloS One 2021;16(7):e0253116. [DOI: 10.1371/journal.pone.0253116] - DOI - PMC - PubMed
    1. Peters JA, Farhadloo M. The effects of non-pharmaceutical interventions on COVID-19 cases, hospitalizations, and mortality: a systematic literature review and meta-analysis. American Journal of Preventive Medicine Focus 2023;2(4):100125. [DOI: 10.1016/j.focus.2023.100125] - DOI - PMC - PubMed